CCM OPEN HF Registry | MicrobiomeTrials← Back to trialsNCT07112924
CCM OPEN HF Registry
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-11-01Est. Completion: 2035-08-15
Enrollment target: 5,500 participants Locations- Cardiovascular Associates of Mesa, Mesa, Arizona, United States
- University of Arizona and Banner University Medical Center Phoenix, Phoenix, Arizona, United States
- HonorHealth Research Institute, Phoenix, Arizona, United States
- Peak Heart and Vascular, Surprise, Arizona, United States
- AdventHealth Orlando, Orlando, Florida, United States
- AdventHealth Tampa, Tampa, Florida, United States
- University of Kansas Medical Center, Kansas City, Kansas, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- University of Michigan, Ann Arbor, Michigan, United States
- Henry Ford Providence Hospital, Novi, Michigan, United States
- Trinity Ann Arbor d/b/a Michigan Heart Ann Arbor, Ypsilanti, Michigan, United States
- Minneapolis Heart Institute Research Foundation, Minneapolis, Minnesota, United States
- Saint Luke's Hospital Mid America Heart Institute, Kansas City, Missouri, United States
- Saint Luke's Hospital of Kansas City, Kansas City, Missouri, United States
- Cardiovascular Specialists of New England Research Foundation, Londonderry, New Hampshire, United States
- Deborah Heart and Lung Center, Browns Mills, New Jersey, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Heart House, Haddon Heights, New Jersey, United States
- Rutgers New Jersey Medical School & University Hospital, Newark, New Jersey, United States
- Oklahoma Heart Hospital Research Foundation, Oklahoma City, Oklahoma, United States
- Providence St. Vincent Medical Center, Portland, Oregon, United States
- Legacy Medical Group Cardiology, Portland, Oregon, United States
- Reading Hospital, West Reading, Pennsylvania, United States
- The Stern Cardiovascular Foundation, Inc, Germantown, Tennessee, United States
Other microbiome trials you might be interested in
IntubationCardiovascular Surgical Procedure
The iCAN trial is a pragmatic randomized controlled trial that aims to test the hypothesis that HFNC versus usual care o…
Nashville, United StatesCompleted Nov 19, 2025
CABGGraft FailureColchicine
This is a single-center, prospective, randomized, open-label, assessor-blinded, blank-controlled exploratory (pilot) tri…
Shanghai, ChinaEst. completion Oct 2027
David Turbay, MD, El Paso, Texas, United StatesTexan Cardiovascular Institute, El Paso, Texas, United StatesCHRISTUS Trinity Mother Frances Health System, Tyler, Texas, United StatesCentra Health, Inc. dba Stroobants Cardiovascular Center, Lynchburg, Virginia, United StatesPeaceHealth Southwest Medical Center, Vancouver, Washington, United StatesAdvocate Aurora Health-St. Lukes, Milwaukee, Wisconsin, United StatesPhase 2
Completed
The purpose of this research study is to see if a study drug called Tocilizumab will, when given with standard anti-reje…
Beverly Hills, United StatesCompleted Mar 25, 2025